The Effect of Hepatic Impairment on the Pharmacokinetics of Intravenously Administered Felcisetrag (TAK‐954)

Felcisetrag (formerly known as TAK‐954) is a selective serotonin receptor agonist under investigation for use in patients with postoperative gastrointestinal dysfunction. The safety, tolerability, and pharmacokinetics (PK) of intravenous (i.v.) felcisetrag have been studied, but little is known abou...

Descripción completa

Detalles Bibliográficos
Autores principales: Czerniak, Richard, Cieslarová, Blanka, Kupčová, Viera, Rosario, Maria, Lock, Ruth, Dong, Cheng, Dukes, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Special Populations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9542772/
https://www.ncbi.nlm.nih.gov/pubmed/35253917
http://dx.doi.org/10.1002/jcph.2044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9542772/
https://www.ncbi.nlm.nih.gov/pubmed/35253917
http://dx.doi.org/10.1002/jcph.2044

Ejemplares similares